EP Patent

EP3681500B2 — Use of pilocarpine hydrochloride for the treatment of presbyopia

Assigned to Allergan Inc · Expires 2025-07-30 · 1y expired

What this patent protects

Patent listed against pilocarpine-hydrochloride.

Drugs covered by this patent

pilocarpine-hydrochloride (PILOCARPINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP3681500B2
Jurisdiction: EP
Classification: —
Expires: 2025-07-30
Drug substance claim: No
Drug product claim: No
Assignee: Allergan Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.